#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10994	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2076	523.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	653	C,A	629,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10994	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2076	523.4	0	HET	.	.	.	C207T,G	.	207	207	C	437	437	C	627	C,T,G	461,145,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20298	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3396	592.7	0	.	n	.	0	T695C	SNP	695	695	T	963	963	C	615	C,T	587,15	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20298	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3396	592.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2239	2239	C	637	C	620	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20298	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3396	592.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2313	2313	A	647	A	637	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20298	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3396	592.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2865	2865	C	606	C,T	584,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20298	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3396	592.7	0	HET	.	.	.	A1638G	.	1638	1638	A	1906	1906	A	658	A,G	331,302	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1396	folP	855	855	100.0	folP.l15.c4.ctg.1	1437	96.3	1	SNP	p	R229S	1	.	.	685	687	AGC	974	976	AGC	153;152;155	A;G;C,T	148;148;146,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3646	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3410	106.4	1	SNP	p	S91F	1	.	.	271	273	TTC	612	614	TTC	117;119;117	T;T;C,T	114;115;114,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3646	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3410	106.4	1	SNP	p	G95N	0	.	.	283	285	GGC	624	626	GGC	119;120;120	G;G,A;C	117;117,1;118	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3646	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3410	106.4	1	SNP	p	D95G	1	.	.	283	285	GGC	624	626	GGC	119;120;120	G;G,A;C	117;117,1;118	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1160	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1312	87.5	1	SNP	p	G45D	0	.	.	133	135	GGC	425	427	GGC	133;132;130	G;G;C	129;130;129	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	622	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	956	64.6	0	.	n	.	0	A197.	DEL	197	197	A	558	558	A	139	A	136	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2858	127.0	1	SNP	p	D86N	0	.	.	256	258	GAC	557	559	GAC	137;136;137	G,A;A;C	127,4;127;132	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2858	127.0	1	SNP	p	R87I	0	.	.	259	261	CGT	560	562	CGT	136;134;134	C,A;G;T	129,4;128;128	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2858	127.0	1	SNP	p	R87W	0	.	.	259	261	CGT	560	562	CGT	136;134;134	C,A;G;T	129,4;128;128	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2858	127.0	1	SNP	p	S87R	1	.	.	259	261	CGT	560	562	CGT	136;134;134	C,A;G;T	129,4;128;128	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2858	127.0	1	SNP	p	S88P	0	.	.	262	264	TCC	563	565	TCC	132;131;130	T;C;C	126;124;124	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3196	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2497	126.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1427	1429	GGC	171;168;168	G;G,T;C	167;164,1;162	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1229	1231	GCC	157;158;159	G,T;C;C	152,1;156;156	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1232	1234	ATG	157;158;158	A;T;G	155;155;154	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1244	1246	ACC	151;150;150	A;C;C	143;146;147	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1244	1246	ACC	151;150;150	A;C;C	143;146;147	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1745	1747	ACC	151;151;150	A;C;C	139;146;144	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1799	1801	GCG	145;144;141	G;C;G	140;138;137	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1799	1801	GCG	145;144;141	G;C;G	140;138;137	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1922	1924	GGT	108;107;105	G;G;T,C	108;106;102,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1931	1933	AGC	96;96;96	A,G;G;C	90,2;95;91	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2942	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2416	119.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1949	1951	CCG	80;80;81	C,G;C;G	69,1;69;59	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4134	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3169	129.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1673	1675	CCG	142;141;140	C;C,T;G	130;129,6;128	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1674	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1913	86.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	587	587	C	110	C	106	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	214	porB1a	984	267	90.41	porB1a.l6.c30.ctg.2	493	13.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	251	253	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	214	porB1a	984	267	90.41	porB1a.l6.c30.ctg.2	493	13.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	254	256	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	214	porB1a	984	267	90.41	porB1a.l6.c30.ctg.2	493	13.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	278	280	GCA	13;13;13	G;C;A	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	214	porB1a	984	267	90.41	porB1a.l6.c30.ctg.2	493	13.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	301	303	GTA	11;13;13	G;T;A	10;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	214	porB1a	984	267	90.41	porB1a.l6.c30.ctg.2	493	13.9	0	.	p	.	0	N237fs	FSHIFT	709	709	A	310	310	A	12	A	12	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2088	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1680	123.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	481	483	GTT	161;162;161	G,A;T,G;T	156,2;155,1;158	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2088	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1680	123.2	1	SNP	p	G120K	1	.	.	358	360	AAG	706	708	AAG	159;161;160	A;A;G	154;158;152	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2088	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1680	123.2	1	SNP	p	A121N	1	.	.	361	363	AAC	709	711	AAC	162;163;163	A,G;A;C,A	156,4;159;155,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2088	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1680	123.2	1	SNP	p	N121D	0	.	.	361	363	AAC	709	711	AAC	162;163;163	A,G;A;C,A	156,4;159;155,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7542	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4848	154.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	884	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1077	81.8	1	SNP	p	V57M	1	.	.	169	171	ATG	534	536	ATG	174;174;174	A;T;G	170;170;169	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
